City
Epaper

Covid-19 pandemic raised antibiotic resistant infections: Study

By IANS | Updated: April 25, 2022 12:50 IST

New York, April 25 People hospitalised during the pandemic both for Covid and other conditions have a higher ...

Open in App

New York, April 25 People hospitalised during the pandemic both for Covid and other conditions have a higher rate of antibiotic-resistant bacterial infections compared to patients hospitalised before the pandemic, according to a study.

An estimated 1.2 million people worldwide died in 2019 from antibiotic-resistant infections, and this number is predicted to increase ten-fold by 2050.

There have been studies reporting that the pandemic was associated with antimicrobial resistance (AMR) secondary infections, possibly due to the increase in the use of antibiotics to treat Covid-19 patients and disruptions to infection prevention and control practices in overwhelmed health systems.

The study, presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) being held in Portugal, evaluated the pandemic's impact on antimicrobial resistance (AMR) in 271 hospitals across the US.

The researchers assessed AMR rates per 100 hospital admissions before and during the Covid pandemic, and examined whether drug-resistant infections were acquired in the community-onset setting (defined as a culture collected less than two days after admission) or in the hospital-onset setting (more than two days after admission).

In total, 1,789,458 patients were admitted to the hospital in the pre-pandemic period and 3,729,208 during the pandemic.

The number of patients admitted to the hospital with at least one AMR infection was 63,263 in the pre-pandemic period and 129,410 during the pandemic.

Patients who tested positive or negative for Covid had higher levels of AMR than patients before the pandemic, 4.92 per 100 admissions and 4.11 per 100 admissions, respectively.

For hospital-associated infections, the AMR rate was 0.77 per 100 admissions before the pandemic and 0.86 per 100 admissions during the pandemic, and highest at 2.19 per 100 admissions in patients with Covid-19.

When looking at community-onset infections, the AMR rate was 2.76 per 100 admissions in the pre-pandemic period, and 2.61 per 100 admissions during the pandemic.

"These new data highlight the importance of closely monitoring the impact of Covid-19 on antimicrobial resistance rates, said Dr Karri Bauer from the US pharmaceutical company Merck.

"It is particularly worrying that antibiotic resistance has been rising during the pandemic in both SARS-CoV-2 positive and negative patients. Hospital-acquired infections are a major concern, with antimicrobial resistance rates significantly higher during the pandemic than before," he added.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: European Congress of Clinical Microbiology and Infectious DiseasesAMR
Open in App

Related Stories

BusinessNational Science Centre and World Animal Protection partnered to raise awareness on irresponsible use of Antibiotics in Animal Farming and Eat Better to End Superbug

NationalWorld Hand Hygiene Day: WHO reiterates its commitment to 'accelerate action together'

BusinessRising Superbug Threat from Factory Farming: Study shows one million deaths aannually and projected doubling by 2050

HealthAntibiotics and resistance 'two-way street' between animals & humans

NationalFICCI writes to Health Ministry on show-cause notices to e-pharmacy companies

National Realted Stories

NationalFive Bangladeshi nationals pushed back for illegal infiltration: Assam CM

National‘Not just half an hour, but Pakistan is half a century behind India’: Owaisi

NationalWords of PM Modi resonate with spirit of seva and nation-building: Tripura CM Saha

National19 people arrested for ‘pro-Pakistan’ stand: Assam CM

NationalSecurity forces kill three NSCN (KYA) militants in Arunachal; rescue construction worker